Breathe Well Live Well
|
Asthma: KOL insights on treatment practices and unmet needs
Sacramento Bee We also gauged opinion during the European Respiratory Society's 2011 Annual Congress on the impact that new clinical data for existing and pipeline products will have on treatment strategies employed by asthma specialists. … |
View full post on asthma – Google News
|
Merck Dulera shows efficacy in COPD treatment
Pharmaceutical Business Review Dulera Inhalation Aerosol, which is used to treat asthma combines mometasone furoate, an inhaled corticosteroid, and formoterol fumarate, a long-acting beta2-agonist. The two 26-week, multicenter, double-blind, placebo controlled trials comprising 2251 … Merck Announces Presentation of Phase III Investigational Studies Evaluating … |
View full post on asthma – Google News
|
Treatment, Medicine Advancements Need Clinical Trial Subjects
Wheeling Intelligencer … vice president for the Pharmaceutical Research and Manufacturers of America, said there are 210 clinical trials throughout the state for six of the most harmful diseases: cancer, diabetes, heart disease, mental illness, stroke and asthma. … New cancer drug |
View full post on asthma – Google News
|
Control of asthma possible with sustained treatment: experts
Business Recorder (blog) Professor Kenneth R. Chapman, Director of the 'Asthma and Airway Center of the University Health Network' spoke about 'Asthma Management Practices and the Role of Seretide.' He emphasised that `Inhaled Corticosteroids are the most effective treatment … |
View full post on asthma – Google News
|
SkyePharma's Asthma Treatment Faces European Approval Delay; Shares Fall
RTT News PK: News ) plunged on the London Stock Exchange in Tuesday morning trade, after the British drug delivery specialist reported a delay in review of the European Marketing Authorisation Application or MAA for its asthma therapy Flutiform due to lack of … SkyePharma lung drug faces European approval delay |
View full post on asthma – Google News
|
A FAR-Out Treatment Approach for Fall Asthma Flare-Ups
Newswise (press release) But for many pediatricians, fall also means more patients with asthma flare-ups. Johns Hopkins Children's Center experts warn that fall is peak asthma time because of high levels of airborne ragweed and mold spores and the arrival of the flu and other … |
View full post on asthma – Google News
|
Efficacy in asthma of once-daily treatment with fluticasone furoate: a …
7thSpace Interactive (press release) Methods: Asthma patients maintained on ICS for [greater than or equal to]3 months with baseline morning forced expiratory volume in one second (FEV1) 50-80% of predicted normal value and FEV1 reversibility of [greater than or equal to]12% and [greater … |
View full post on asthma – Google News
 UCSF Today |
Asthma Treatment May Be Headed Toward Personalized Medicine
UCSF Today Asthma patients could clearly benefit from personalized medicine, a new study suggests. However, the new discovery of a key gene, while exciting, does not mean that day is here quite yet. Asthma treatment response … |
View full post on asthma – Google News
 Los Angeles Times |
Gene Variant Could Explain Why Asthma Treatment Often Fails
MIT Technology Review A new study has revealed a genetic variant among asthma patients who don't respond well to steroid inhalers, the main treatment for the disease. The discovery could lead to a DNA test that could identify such patients early on, … Gene could explain why asthma treatments fail some What asthma means for those who have it Gene variant associated with reduced response to asthma inhalers |
View full post on asthma – Google News
 Fox News |
Asthma treatment Primatene Mist to leave market at year's end
Tampabay.com If you are among the 2 million Americans depending on a drugstore inhaler to deal with asthma, it may be time to schedule a doctor's appointment. At the end of the year, your only non-prescription treatment option … Popular Asthma Inhaler to Be Pulled Off the Market Popular asthma inhaler pulled due to environmental concerns International Ban on CFCs Claims Cheap, Over-Counter Inhalers |
View full post on asthma – Google News